Is there any difference between Sotoracib (AMG510) produced by Bangladesh Everest and that produced by Ziska Pharmaceuticals? Is the effect the same?

Sotoracib (AMG510) is a small molecule drug that selectively and irreversibly targets KRAS G12C. It is used to treat patients with non-small cell lung cancer. It is the first targeted drug targeting the KRAS G12C mutation and has a relatively high effectiveness.

Currently, sotoracib is produced by many pharmaceutical factories. Bangladesh has Everest Pharmaceuticals and Ziskar Pharmaceuticals. Bangladesh Everest Pharmaceuticals will be launched in Bangladesh in 20223. The retail price of the pharmaceutical factory is120mg56 capsules4 span>Around one thousand, Bangladesh Ziska Pharmaceuticals will be launched in Bangladesh in December 2022. The retail price of 120mg56 tablets is around one thousand. Different pharmaceutical companies have different pricing. Everest was launched earlier and has been used by more patients before. It is currently produced by many pharmaceutical companies, not limited to Everest Pharmaceutical Factory. Both versions are officially marketed in Bangladesh. The dosage and specifications of the drug ingredients are the same, so there is no difference. Patients can choose drug versions based on their financial situation.

Sotoracib may cause side effects, if these symptoms are severe or do not go away, please tell your doctor immediately, such as diarrhea, vomiting, nausea, constipation, loss of appetite, Stomach pain, Fatigue, Muscle or bone pain, Joint pain, Yellow skin or eyes, darker urine, bleeding or bruising more easily than normal, loss of appetite, decreased energy, or pain on the right side of the stomach, Shortness of breath, cough or fever, etc. If you want to get more high-quality information, you can contact YaoDe. YaoDe will do its best to learn more about high-quality overseas drugs for you.